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Cellular longevity is a complex process relevant to age-related diseases including but not limited to chronic ill-
ness such as diabetes and metabolic syndromes. Two gene families have been shown to play a role in the genetic 
regulation of longevity; the Sirtuin and FOXO families. It is also established that nuclear Sirtuins interact with 
and under specific cellular conditions regulate the activity of FOXO gene family proteins. Thus, we hypothesize 
that a mitochondrial Sirtuin (SIRT3) might also interact with and regulate the activity of the FOXO proteins. To 
address this we used HCT116 cells overexpressing either wild-type or a catalytically inactive dominant negative 
SIRT3. For the first time we establish that FOXO3a is also a mitochondrial protein and forms a physical interac-
tion with SIRT3 in mitochondria. Overexpression of a wild-type SIRT3 gene increase FOXO3a DNA-binding ac-
tivity as well as FOXO3a dependent gene expression. Biochemical analysis of HCT116 cells over expressing the 
deacetylation mutant, as compared to wild-type SIRT3 gene, demonstrated an overall oxidized intracellular en-
vironment, as monitored by increase in intracellular superoxide and oxidized glutathione levels. As such, we 
propose that SIRT3 and FOXO3a comprise a potential mitochondrial signaling cascade response pathway. 
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Introduction 
One theme emerging over the last several years is 
that aging is a complex, genetically regulated cellular 
process [1]. Genes critical to longevity have been iso-
lated and characterized in several model systems in-
cluding yeast and C. elegans [1]. Sirtuin family genes 
first came to attention because their Saccharomyces cer-
evisiae homolog (Sir2) was shown to regulate both rep-
licative and overall lifespan by caloric restriction (CR) 
[2]. In humans and mice there are seven Sirtuins, two 
that are located in the nucleus (SIRT1, 6, and 7), one in 
the cytoplasm and nucleus (SIRT2), and 3 are localized 
to the mitochondria (SIRT3, 4, and 5) [3]. While yeast 
Sir2 is a NAD+ dependent deacetylase, mammalian 
Sirtuins have more varied targets, including either 
deacetylase or ADP-ribosyltransferase activity [4]. 
It is clear that sirtuins regulate a series of essential 
intracellular processes that defend the cell against 
multiple types of cellular damage, including oxidative 
damage [5]. These observations imply that Sirtuin 
genes may be metabolic guardians that could play a 
central role in longevity by regulating cellular or or-
ganelle renewal. That is, as cells and critical intracel-
lular organelles slowly degrade from age related oxi-
dative stress, Sirtuin genes may respond to this by 
activating signaling pathways to repair damage. 
When outlining a course of investigation for the 
potential role of Sirtuins as organelle surveillance 
genes, we chose to examine the mitochondrial inner 
membrane protein SIRT3 for several reasons. First, it 
has long been suggested that the mitochondria play a 
role in aging and oxidative stress [6]. Second, mito-
chondrial electron transport chains reduce of O2 to Int. J. Biol. Sci. 2008, 4 
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form superoxide (O2
•-), leading to oxidative stress 
which plays a role in genomic instability and aging 
[7,8]. Third, SIRT3 localization to the inner mitochon-
drial membrane is consistent with a role in monitoring 
and responding to conditions harmful to electron 
transport, activating processes to minimize mitochon-
drial damage   
The  FOXO family of transcription factors: 
FOXO1, FOXO3a, FOXO4 and FOXO6 are the human 
homologs of the daf-16 C. elegans gene. Daf-16 is the 
master regulator of dauer formation [9] and contrib-
utes to the regulation of lifespan in nematodes [10]. 
FOXO transcription factors appear to regulate a wide 
range of intracellular processes including metabolism 
and cellular resistance to various forms of oxidative 
stress [11,12]. It is also established that sirtuins interact 
with, and under specific cellular conditions, regulate 
that activity of FOXO gene family proteins [13,14]. 
Thus, we chose to investigate if SIRT3 might also in-
teract with and regulate the activity of any of the 
FOXO proteins. 
MATERIALS AND METHODS 
Cell lines and Plasmids 
HCT-116 (human colon carcinoma) and Cos-7 
cells were cultured in McCoy’s 5A media, containing 
10% heat-inactivated (56°C, 30min) fetal bovine serum 
(FBS) and. supplemented with penicillin (100 
Units/mL) and streptomycin (100μg/mL). The ex-
pression vector pcDNA4 was obtained from Promega, 
Inc. pCMV-SIRT3-wt and pCMV-SIRT3-mt were a 
kind gift from Toren Finkel (National Institutes of 
Health). These expression plasmids express either the 
wild-type gene or an acetylation null gene where 
amino acid 248 has been changed from a histidine to 
tyrosine [15]. Permanent cell lines expressing 
wild-type SIRT3 (wt-SIRT3) or the deacetylase mutant 
(mt-SIRT3) (supplemental Fig. S1) were constructed by 
transfecting pcDNA4, pCMV-SIRT3-wt, or 
pCMV-SIRT3 in HCT116 cells using FuGene 6 and 
selected with zeosin (supplemental Fig. S2). For this 
work cell lines expressing the various SIRT3 genes are 
referred to as wt-SIRT3 or mt-SIRT3 while plasmids 
expressing these genes are denoted as 
pCMV-SIRT3-wt or pCMV-SIRT3-mt (supplemental 
Fig. S1). The FOXO3a expression plasmids 
(pCMV-wt-FOXO3a, pCMV-m-FOXO3a, and 
pCMV-N-FOXO3a) were obtained from Addgene 
(Cambridge, Ma). 
IP and Mitochondrial Fractionation 
Cell extracts were prepared using a modification 
of the previously described method [16,17] and protein 
concentrations were determined using the Bradford 
assay (BioRad Labs., Hercules, CA) on a Beckman 
DU-640 spectrophotometer. Mitochondria extracts 
were prepared using kit provided by Pierce (Rockford, 
Il). Briefly cells were lysed by dounce homogenization 
in lysis buffer followed by centrifugation at 700 x g to 
remove the nuclear fraction along with cell debris. The 
supernatant was then spun at 3,000 x g for 15 minuets 
to isolate the mitochondria fraction. Trypan blue ex-
clusion analysis was performed to check for lysis effi-
ciency following dounce homogenization. Western 
samples were loaded into denaturing 
SDS-polyacrylamide gels, membranes were probed 
with anti-SIRT3 (See supplement) or anti-FOXO3a an-
tibodies (Santa Cruz Biotechnology, Santa Cruz, CA) 
and incubated with horseradish peroxi-
dase-conjugated secondary antibody (Santa Cruz Bio-
technology, Santa Cruz, CA).  
Co-transfections, Luciferase Assays, and Chroma-
tin Immunoprecipitation 
For transient assays, cells were plated at 2 ×106 
cells per 100-mm plate, co-transfected, and harvested 
after 36 hrs. Cells were co-transfected with 1 µg of 
pCMV-β-gal and analysis for luciferase and 
β-galactosidase activity. Luciferase activity was nor-
malized to β-galactosidase activity and the results are 
presented as luciferase/β-galactosidase relative units. 
The results are presented as relative-fold induction 
over the sham treated control. 
Chromatin Immunoprecipitation 
Cells were cultured for 24h and prepared using a 
ChIP assay kit from Upstate Biotechnology, Inc. (Lake 
Placid, NY) according to the manufacturer’s recom-
mendations and preformed as previously describe 
[28]. Primers for the FOXO3a and SCO2 promoter are 
shown (Supplemental Methods) and their location is 
shown in supplemental Fig. S3. IP and transient 
transfection IP westerns were done as previously de-
scribed [28]. Bands for all IPs were detected using an 
ECL protocol (Santa Cruz Biotechnology, Santa Cruz, 
CA) and visualized with Fuji Las-3000 intelligent 
darkbox (FujiFilm Medical Systems, Stamford, CT).  
Intracellular superoxide measurements and thiol 
analysis  
Steady state levels of superoxide were estimated 
using the fluorescent dye, dihydroethidium (DHE) as 
described in Slane et al [8]. Glutathione (GSH) and 
glutathione disulfide (GSSG) contents were deter-
mined by the recycling method [18] and a yellow color 
change was detected spectrophotometrically at 412 nm 
as DTNB is converted to TNB by the conversion of 2 
GSH to GSSG.” Int. J. Biol. Sci. 2008, 4 
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RESULTS 
The daf-16 homolog, FOXO3a, forms a complex 
with SIRT3 
The FOXO family of transcription factors regulate 
metabolism and confer stress resistance [11,12]. It has 
also been shown that the well studied SIRT1 interacts 
with, and under specific cellular conditions, regulates 
the activity of FOXO gene family proteins [14,19]. We 
sought to establish whether the mitochondrial local-
ized SIRT3 may also form a physical interaction with 
the FOXO family protein, FOXO3a, using 
co-immunoprecipitation (Co-IP) techniques. Car-
boxy-terminally myc tagged wild-type 
(p-myc-hSIRT3-wt), and mutant (p-myc-hSIRT3-mt) 
SIRT3 expression vectors were transfected into Cos-7 
cells followed by Co-IP with an anti-myc antibody. 
Western analysis with an anti-FOXO3a antibody sub-
sequently showed a physical interaction between both 
wild-type and mutant SIRT3 with FOXO3a (Fig. 1A). 
To ensure that this interaction was not an artifact of the 
COS-7 cell line, or the transient transfection conditions, 
HCT116 cells, which contain undetectable levels of 
endogenous SIRT3 by western analysis, were stably 
transfected with p-myc-hSIRT3-wt, and 
p-myc-hSIRT3-mt  SIRT3 expression vectors (Fig S2). 
These cells were used to determine if the FOXO3a – 
SIRT3 interaction occurs in the mitochondria or the 
cytosol.  Co-IP experiments were repeated using the 
HCT116  SIRT3 expressing stable cell lines. FOXO3a 
was found to interact with SIRT3 in both whole cell 
(Fig. 1B) and mitochondrial extracts (Fig. 1C). All frac-
tions and samples in the Co-IP experiments were 
checked for the presence of SIRT3, using a SIRT3 spe-
cific antibody (Biomol, Plymouth Meeting , PA), as 
well as tubulin (Santa Cruz Biotechnology, Santa Cruz, 
CA), and Cytochrome C (Mitosciences, Eugene, OR) to 
ensure fraction purity (data not shown). These ex-
periments demonstrate that both wild type and mutant 
SIRT3 form a physical interaction with FOXO3a in 
mitochondrial extracts.  
 
Figure 1. The daf-16 homolog, FOX3a forms a complex with 
SIRT3. (A) FOXO3a binds to SIRT3 in vitro. Cos-7 cells were 
transfected with either SIRT3 wild-type (p-myc-hSIRT3-wt) or 
deacetylation mutant (p-myc-hSIRT3-mt) vectors and cell lys-
ates were immunoprecipitated (IPd) with an anti-Myc antibody 
followed by Western analysis with an anti-FOXO3a antibody. 
(B) HCT116 cell lysates were IPd with either an anti-FOXO3a 
or anti-SIRT3 antibody, resolved by SDS-PAGE, and im-
munoblotted with anti-FOXO3a antibody. (C) Mitochondrial 
factions from HCT116 cells were IPd with either an 
anti-FOXO3a or anti-SIRT3 antibody and immunoblotted with 
anti-FOXO3a antibody.  
FOX3a is a mitochondrial protein  
FOXO3a interacts with SIRT3 in mitochondrial 
extracts in vitro thus, we chose to investigate if any of 
the FOXO3a proteins might be localized to the mito-
chondrial tissue lysates as well. Western analysis of 
mitochondrial samples from human heart (Fig. 2A) 
and liver (Fig. 2B) (Microscience, Inc) lysates clearly 
shows that FOXO3a is present in the mitochondrial 
cellular fractions. Anti-tubulin and anti-cytochrome C 
antibodies were used as controls to determine mito-
chondrial and non-mitochondrial protein fractions. As 
expected, similar results were seen in HCT116 and 
HCT116 cells genetically altered to express either the 
wild-type or deacetylation null SIRT3 genes (Fig. 2C). 
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Figure 2. The daf-16 homolog, FOX3a is a mitochondrial 
protein. Mitochondrial protein fraction from heart (A) and liver 
(B) (DNA Technologies, ReadyWestern™) were analyzed by 
western analysis for the presence of the FOXO3a protein. The 
PVDF membrane was also probed with both and a-tubulin and 
a-cytochrome c antibodies that localize to the cytoplasm and 
mitochondria, respectively. (C) Mitochondrial protein fractions 
from of pcDNA, wt-SIRT3, or mt-SIRT3 cell lines were isolated 
and immunoreactive FOXO3a protein levels were determined.  
SIRT3 activates FOXO3a dependent gene expres-
sion.  
To determine if FOXO3a activates promoter ac-
tivity in our system, three FOXO3a expression vectors 
were employed that: (1) express the wild-type gene 
that is still inhibited by Akt (pCMV-FOXO3a-wt); (2) 
express a mutant gene that appears to be a dominant 
negative (pCMV-mt-FOXO3a); and (3) express a 
dominant positive (constitutively active) gene that 
cannot be phosphorylated and inhibited by Akt 
(pCMV-N-FOXO3a) [20]. Co-transfection of these three 
plasmids with p3400-MnSOD-Luc, which contains the 
MnSOD promoter and its two consensus FOXO bind-
ing sites (supplemental Fig. S3) cloned upstream of 
luciferase, demonstrated that pCMV-N-FOXO3a in-
creased p3400-MnSOD-Luc luciferase activity (Fig. 3A, 
bar 3). In contrast, co-transfection with 
pCMV-mt-FOXO3a decreased MnSOD expression of 
the reporter (bar 2) as compared to the control, 
wild-type vector, pCMV-wt-FOXO3a (bar 1). These 
results clearly demonstrate that FOXO3a can activate 
the expression of the reporter gene.  
A  FOXO3a luciferase reporter construct was 
made that contains three FOXO3a binding sites fused 
to the luciferase gene (p3x-FOXO-tk-Luc) and this re-
p o r t e r  v e c t o r  w a s  u s e d  t o  d e t e r m i n e  FOXO3a de-
pendent gene expression as measured by luciferase 
levels. p3x-FOXO-tk-Luc was subsequently 
co-transfected into HCT116 cells with either 
pCMV-SIRT3-wt or pCMV-SIRT3-mt expression vec-
tors. Expression of the wild-type SIRT3 increases 
luciferase activity (Fig. 3B, bar 1 versus bar 2). These 
results show that SIRT3 activates FOXO3a dependent 
gene expression. 
To determine if FOXO3a is downstream of SIRT3 
in the activation of the p3x-FOXO-Luc the reporter 
plasmid was co-transfected with either the wild-type 
or mutant SIRT3 expression vector (as done in Fig. 3B), 
and either pCMV-wt-FOXO3a or pCMV-mt-FOXO3a. 
These experiments will determine if a mutant FOXO3a 
protein will change the ability of SIRT3 to activate 
p3x-FOXO-tk-Luc gene expression. Transfection of 
p3x-FOXO-tk-Luc or pCMV-SIRT3-wt (bar 2) is a 
positive control and is identical to Fig. 2B, bar 1. In 
contrast, co-transfection of pCMV-SIRT3-wt with a 
mutant  FOXO3a expression vector 
(pCMV-mt-FOXO3a) decreased p3x-FOXO-tk-Luc 
driven luciferase activity (Fig. 3C, bar 2 versus 3. These 
results suggest that in transient assays FOXO3a de-
pendent gene expression that is induced by SIRT3 is 
prevent by expression of a mutant FOXO3a protein. 
ChIP analysis showed that wt-SIRT3 cells have an 
increase in FOXO3a binding to upstream regulatory 
regions of gene promoters that each contain two ca-
nonical FOXO3a binding sites roughly 1 kb upstream 
of the transcription start site (supplemental Fig. S3). 
FOXO3a binding to both the MnSOD (Fig.3D, upper 
panel) and SCO2 (lower panel) promoters is increased 
in the wt-SIRT3, as compared to mt-SIRT3 cells. These 
experiments imply that SIRT3 may increase FOXO3a 
DNA-binding. Int. J. Biol. Sci. 2008, 4 
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Figure 3. SIRT3 activates FOXO3a dependent gene expression. (A) pMnSOD-Luc was transiently co-transfected with CMV 
based FOXO3a expression vectors encoding the wild-type (pCMV-wt-FOXO3a), dominant negative (pCMV-m-FOXO3a), or 
dominant positive (pCMV-N-FOXO3a) FOXO3a genes. Results for all the experiments presented in this figure were normalized to 
β-galactosidase activity and the results are presented as luciferase/β-galactosidase relative units. (B) SIRT3 activates FOXO3a 
dependent gene expression. A reporter plasmid containing three FOXO DNA-binding sites (p3x-FOXO-Luc) was transfected with 
either pCMV-SIRT3-wt or pCMV-SIRT3-mt and luciferase activity was determined as described above. (C) The p3x-FOXO-Luc 
reporter plasmid was transfected with wild type or mutant FOXO3a expression vectors (pCMV-wt-FOXO3a or pCMV-m-FOXO3a 
respectively) along with wild type or mutant SIRT3 expression vectors (pCMV-SIRT3-wt or pCMV-SIRT3-mt) and luciferase 
activity was determined and normalized to β-galactosidase as described above. All experiments are mean of at least three separate 
experiments and error bars for all data shown represent one standard deviation and statistical significance was established by Stu-
dent's t-test. * Indicates P < 0.05 by t-test. (D) ChIP analysis of FOXO3a finding to the MnSOD and SCO2 promoters in HCT116 
cells that overexpress either a wild-type or deacetylation null SIRT3 gene. Cells were fixed with 1% formaldehyde to crosslink 
protein-DNA interactions, sonicated, and fixed cells were immunoprecipitated with either an anti-FOXO3a antibody. DNA was 
eluted and purified before analysis specific primers and visualized by ethidium bromide staining.  
 
Overexpression of SIRT3 induced MnSOD 
p3400-MnSOD-Luc was transfected into HCT116 
cells genetically altered to over express either 
wild-type (wt-SIRT3) or a catalytically inactive deace-
tylation mutant (mt-SIRT3) SIRT3 gene (Supplemental 
Fig. S1). HCT116 cells were used since they have 
nearly undetectable SIRT3 protein (data not shown). 
These results showed an increase in luciferase activity 
in cells overexpressing the wild-type SIRT3 gene, as 
compared to the mutant gene (Fig. 4A). 
p3400-MnSOD-Luc was also co-transfected into 
HCT116 cells with either pCMV-SIRT3-wt or 
pCMV-SIRT3-mt SIRT3 expression vector. These tran-
sient transfection experiments showed that that SIRT3, 
but not the deacetylation mutant gene, induces 
MnSOD promoter activity (Fig. 4B).  Int. J. Biol. Sci. 2008, 4 
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SIRT3 alters intracellular superoxide levels 
SIRT3 is localized in the inner mitochondrial 
membrane [21] along with the electron transport chain. 
The mitochondria are a major source of superoxide 
formation; and the accumulation of superoxide, from 
decreased election transport, is thought be a source of 
oxidative damage associated with degenerative dis-
eases and aging [22]. Thus, it seemed logical to pro-
pose that one function of SIRT3 may be to mediate 
intracellular superoxide levels. HCT116 based 
wt-SIRT3 or mt-SIRT3 cells were isolated and intra-
cellular superoxide levels were estimated by DHE 
oxidation [8]. These experiments showed that SIRT3 
deacetylation mutant cells (mt-SIRT3) have signifi-
cantly increased intracellular superoxide (O2●-) levels 
[8], relative to either vector control or wt-SIRT3 cells 
(Fig. 5A). Intracellular reduced (GSH) and oxidized 
glutathione (GSSG) concentrations were also altered in 
mutant mt-SIRT3 cells, relative to either vector control 
or wt-SIRT3 cells, consistent with a relatively oxidizing 
intracellular environment in the Sirt3 mutant express-
ing cells (Fig. 5B).   
 
 
 
   
Figure 4. Overexpression of SIRT3 induced MnSOD expression. (A) A MnSOD promoter luciferase reporter plasmid 
(pMnSOD-Luc) was transfected into wt-SIRT3, mt-SIRT, and vector control cell lines. Luciferase activity was normalized to 
β-galactosidase activity and presented as luciferase/β-galactosidase relative units. All results are the mean of at least three separate 
experiments. Error bars around data points represent one standard deviation about the arithmetic mean. (B) pMnSOD-Luc was 
co-transfected into HCT116 cells with either pCMV-SIRT3-wt or pCMV-SIRT3-mt expression vectors or luciferase assays were 
done as described above. * Indicates P < 0.05 by t-test. Int. J. Biol. Sci. 2008, 4 
 
297
 
Figure 5. SIRT3 expression alters intracellular superoxide levels. (A) Altered steady-state levels of superoxide as shown by 
increased oxidation of DHE in HCT116 SIRT3 overexpressing cells. Control (pcDNA vector), wild-type SIRT3 (wt-SIRT3), or a 
deacetylation SIRT3 mutant (mut-SIRT3) cell lines were analyzed by flow cytometry for the amount of hydrolyzed DHE per 10,000 
cells represented as Mean Florescent Intensity (MFI). Each bar represents the average of three separate experiments. Error bars 
indicate standard error. * Indicates P < 0.05 by t-test. (B) SIRT3 overexpressing cells contain increased GSH/GSSG redox ratios. 
Total levels of glutathione (GSH) was determined and normalized to total protein (left panel). GSSG/GSH ratios were determined 
and represented as % GSSG (right panel). Error bars represent of standard deviation of three independent experiments. * Indicates P 
< 0.05 by t-test. 
 
DISCUSSION 
In this study, we suggest that FOXO3a is a mito-
chondrial protein and its function may be regulated by 
a physical interaction with SIRT3 in the mitochondria. 
This idea is based on the observations that: (1) FOXO3a 
is present in the mitochondria and physically interacts 
with SIRT3; (2) SIRT3 increases the DNA-binding of 
FOXO3a at two promoters resulting in an increase in 
gene expression; and (3) altered SIRT3 function results 
in altered and increased intracellular O2●-. The results 
of these experiments all support the hypothesis that 
SIRT3 may be a mitochondrial surveillance factor that 
detects metabolic imbalances involving O2
•- production 
and induces specific pathways to respond to these 
conditions. 
While it is tempting to suggest that SIRT3 is ini-
tiating a signaling pathway in the mitochondria and 
sending it to the nucleus to activate gene expression 
via FOXO3a our results do not confirm this specific 
idea and the experimental assays to validate this idea 
do not exist. However, one possibility is that SIRT3 is 
both a mitochondrial and a cytoplasmic protein. Sev-
eral manuscripts have been published suggest that 
SIRT3 is a mitochondrial protein [21,22] while others 
imply a more complex cellular localization pattern 
[24,25]. In our two model systems using HCT116 and 
SIRT3 knockout derived MEFs, SIRT3 appears present 
only in the mitochondria. However, this does not rule 
out a small amount of the protein might be in either the 
cytoplasm or nucleus.  
Several previous publications suggest that SIRT3 
may play a role in the regulation of mitochondrial 
metabolism [26] as well as acetyl-CoA synthetase ace-
tylation [4]. It also appears that SIRT3 is the primary 
mammalian Sir2 homolog that regulates global mito-
chondrial lysine acetylation [1]. However, the mecha-
nism and physiological function of SIRT3 has not been 
determined. The results presented here, when coupled 
with others, suggest that at least one function of SIRT3 
serves as a sensor of small reactive oxygen molecules 
and initiates specific cellular signaling pathways. In 
this model the induction of SCO2 and MnSOD would 
be an appropriate response to detoxification O2
•-. 
The mitochondria are key organelles that main-
tain multiple cellular processes and decreases in func-
tion are critical to age-related diseases such as diabetes, 
neurodegeneration, and carcinogenesis [27]. SIRT3 is 
located near the electron transport chain [28] and is at 
an ideal location to function as a guardian gene against 
the accumulation of small reactive molecules that 
might induce cellular damages. Mitochondria are a 
major source of superoxide formed by the reduction of 
oxygen during electron transport. The oxidative 
damage caused by the reactive oxygen species derived 
from superoxide is believed to be a major cause of de-
generative diseases associated with aging [22]. How-
ever, it has also been suggested that that physiological 
levels of O2
•- and H2O2 production are essential for 
normal biological signaling processes leading to the 
attainment of a normal lifespan [26]. Thus, these re-
sults suggest a potential mechanism where the normal 
production of reactive oxygen species, such as O2●-, 
induces specific pathways that act to repair and, per-
haps more importantly, to renew organelle functions. 
On the other hand, the induction of proteins such 
as SCO2, should decrease O2
•- levels indirectly by in-
creasing the efficiency of the four electron reduction of 
O2. SCO2 is a mitochondrial membrane-bound protein 
involved in copper supply for the assembly of cyto-Int. J. Biol. Sci. 2008, 4 
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chrome c oxidase (CcO) [29]. CcO catalyzes the 
four-electron reduction of molecular oxygen to H2O 
and couples this reduction with proton translocation 
across the inner membrane to improve mitochondrial 
respiration efficiency [30]. CcO increases the efficiency 
of four electron transfer to O2 to 2H2O in Complex IV 
and as such, reduces the residence time of electrons at 
upstream sites capable of mediating one electron re-
ductions of O2. Thus, the induction of SCO2 could 
theoretically decrease O2
•- production at sites in the 
electron transport chains upstream of Complex IV 
(Complexes I, II, and III). 
This work also suggests that there may be mito-
chondrial surveillance genes that sense organelle dis-
tress and pass signals to the nucleus to initiate the ex-
pression of nuclear genes to prevent or repair any 
functional damage to mitochondria. While no direct 
mechanism is presented for how this signaling is 
transduced out of the mitochondria, it does seem 
logical that such a reparative pathway would exist and 
has been proposed by others [27]. Finally, since SIRT3 
is the primary deacetylase in the mitochondria [1] we 
would propose that deacetylation, perhaps induced by 
nutrient deprivation or oxidative stress, may activate 
families of evolutionary conserved reparative genes. 
Supplementary Material 
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